Substituted pyrido-pyridazine derivatives which enhance cognition via the gaba-a receptors
AssigneeMerck Sharp & Dohme Corp.
InventorsSimon Goodacre, David Hallett
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerck Sharp & Dohme Corp.
InventorsSimon Goodacre, David Hallett
Estimating the term…
The present invention discloses a compound of formula 1, or a pharmaceutically acceptable salt thereof: wherein X1 represents hydrogen, halogen, C1-6 alkyl, trifluoromethyl or C1-6 alkoxy; X2 represents hydrogen or halogen; Y represents a chemical bond, an oxygen atom, or a —NH— linkage; Z represents an optionally substituted aryl or heteroaryl group; R1 represents hydrogen, hydrocarbon, a heterocyclic group, halogen, cyano, trifluoromethyl, nitro, —ORa, —SRa, —SORa, —SO2Ra, —SO2NRaRb, NRaRb, —NRaCORb, —NRaCO2Rb, —CORa, —CO2Ra, —CONRaRb or —CRa&=NORb; and Ra and Rb independently represent hydrogen, hydrocarbon or a heterocyclic group; a pharmaceutical composition comprising it; its use in a method of treatment; use of it to manufacture a medicament; and a method of using it to prevent or treat anxiety, convulsions or cognitive disorders.
1-10. (canceled)
A compound of formula I, or a pharmaceutically acceptable salt thereof:
The compound of claim 1 of formula IIA:
The compound of claim 1 of formula IIB:
The compound of claim 1 of formula IIC:
The compound of claim 1 of formula IID:
A compound which is 2′-fluoro-5′-(7-trifluoromethylpyrido[2,3-c]pyridazin-4-yl)biphenyl-2-carbonitrile or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition comprising the compound of claims 1, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient.
A method for the treatment of anxiety, convulsions or cognitive disorders, which comprises administering to a patient in need of such treatment an effective amount of the compound of claim 1, or a pharmaceutically acceptable salt thereof.
A method for the prevention of anxiety, convulsions or cognitive disorders, which comprises administering to a patient in need of such prevention an effective amount of the compound of claim 1, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.